Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]

Heather J Cordell¹, James J Fryett¹, Kazuko Ueno², Rebecca Darlay¹, Yoshihiro Aiba³, Yuki Hitomi⁴, Minae Kawashima⁴, Nao Nishida⁴, Seik-Soon Khor², Olivier Gervais⁵, Yosuke Kawai², Masao Nagasaki⁵, Katsushi Tokunaga², Ruqi Tang⁶, Yongyong Shi⁷, Zhiqiang Li⁷, Brian D Juran⁸, Elizabeth J Atkinson⁹, Alessio Gerussi¹⁰, Marco Carbone¹⁰, Rosanna Asselta¹¹, Angela Cheung⁸, Mariza de Andrade⁹, Aris Baras¹², Julie Horowitz¹², Manuel A R Ferreira¹², Dylan Sun¹², David E Jones¹³, Steven Flack¹⁴, Ann Spicer¹⁴, Victoria L Mulcahy¹⁴, Jinyoung Byan¹⁵, Younghun Han¹⁵, Richard N Sandford¹⁴, Konstantinos N Lazaridis⁸, Christopher I Amos¹⁵, Gideon M Hirschfield¹⁶, Michael F Seldin¹⁷, Pietro Invernizzi¹⁰, Katherine A Siminovitch¹⁸, Xiong Ma⁶, Minoru Nakamura³, George F Mells¹⁹; Canadian PBC Consortium; Chinese PBC Consortium; Italian PBC Study Group; Japan-PBC-GWAS Consortium; US PBC Consortium; UK-PBC Consortium

Affiliations

¹ Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
² Genome Medical Science Project, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
³ Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Omura, Japan.
⁴ Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Human Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, Shanghai, China.
⁷ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China; Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China.
⁸ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
⁹ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
¹⁰ Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
¹¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
¹² Regeneron Genetics Center, Tarrytown, New York, USA.
¹³ Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
¹⁴ Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
¹⁵ Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
¹⁶ Toronto Centre for Liver Disease, Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada.
¹⁷ University of California, Davis, California, USA.
¹⁸ Departments of Medicine, Immunology and Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute and Toronto General Research Institute, Toronto, Ontario, Canada.
¹⁹ Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom. Electronic address: gfm26@cam.ac.uk.

PMID: 36639314
DOI: 10.1016/j.jhep.2022.12.001

Published Erratum

Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]

Heather J Cordell et al. J Hepatol. 2023 Apr.

. 2023 Apr;78(4):883.

doi: 10.1016/j.jhep.2022.12.001. Epub 2023 Jan 11.

Authors

Affiliations

¹ Population Health Sciences Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
² Genome Medical Science Project, National Center for Global Health and Medicine (NCGM), Tokyo, Japan.
³ Clinical Research Center, National Hospital Organization, Nagasaki Medical Center, Omura, Japan.
⁴ Department of Human Genetics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
⁵ Human Biosciences Unit for the Top Global Course Center for the Promotion of Interdisciplinary Education and Research, Kyoto University, Kyoto, Japan; Center for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
⁶ Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, State Key Laboratory for Oncogenes and Related Genes, Renji Hospital, School of Medicine, Shanghai JiaoTong University, Shanghai Institute of Digestive Disease, Shanghai, China.
⁷ Bio-X Institutes, Key Laboratory for the Genetics of Developmental and Neuropsychiatric Disorders (Ministry of Education), Collaborative Innovation Center for Brain Science, Shanghai Jiao Tong University, Shanghai, China; Affiliated Hospital of Qingdao University and Biomedical Sciences Institute of Qingdao University (Qingdao Branch of SJTU Bio-X Institutes), Qingdao University, Qingdao, China.
⁸ Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
⁹ Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
¹⁰ Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER), San Gerardo Hospital, Monza, Italy.
¹¹ Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy; Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy.
¹² Regeneron Genetics Center, Tarrytown, New York, USA.
¹³ Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.
¹⁴ Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
¹⁵ Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.
¹⁶ Toronto Centre for Liver Disease, Division of Gastroenterology and Hepatology, University of Toronto, Toronto, Ontario, Canada.
¹⁷ University of California, Davis, California, USA.
¹⁸ Departments of Medicine, Immunology and Medical Sciences, University of Toronto, Toronto, Ontario, Canada; Mount Sinai Hospital, Lunenfeld-Tanenbaum Research Institute and Toronto General Research Institute, Toronto, Ontario, Canada.
¹⁹ Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom. Electronic address: gfm26@cam.ac.uk.

PMID: 36639314
DOI: 10.1016/j.jhep.2022.12.001

No abstract available

PubMed Disclaimer

Erratum for

An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs.
Cordell HJ, Fryett JJ, Ueno K, Darlay R, Aiba Y, Hitomi Y, Kawashima M, Nishida N, Khor SS, Gervais O, Kawai Y, Nagasaki M, Tokunaga K, Tang R, Shi Y, Li Z, Juran BD, Atkinson EJ, Gerussi A, Carbone M, Asselta R, Cheung A, de Andrade M, Baras A, Horowitz J, Ferreira MAR, Sun D, Jones DE, Flack S, Spicer A, Mulcahy VL, Byan J, Han Y, Sandford RN, Lazaridis KN, Amos CI, Hirschfield GM, Seldin MF, Invernizzi P, Siminovitch KA, Ma X, Nakamura M, Mells GF; PBC Consortia; Canadian PBC Consortium; Chinese PBC Consortium; Italian PBC Study Group; Japan-PBC-GWAS Consortium; US PBC Consortium; UK-PBC Consortium. Cordell HJ, et al. J Hepatol. 2021 Sep;75(3):572-581. doi: 10.1016/j.jhep.2021.04.055. Epub 2021 May 23. J Hepatol. 2021. PMID: 34033851 Free PMC article.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]

Affiliations

Corrigendum to: "An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs" [J Hepatol 75 (2021) 572-581]

Authors

Affiliations

Erratum for

Publication types

LinkOut - more resources

Full Text Sources